Dolutegravir/Rilpivirine, Antiretroviral Efficacy Study Using Real-world Data in Subjects With Human Immunodeficiency Virus (HIV)-1
Clinical trial NCT03518060 · COMPLETED
Trial details
- NCT number
- NCT03518060
- Sponsor
- ViiV Healthcare
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2018-06-25
- Primary completion
- 2023-05-14
- Enrollment
- 209
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.